ATU Sligo /ATU St Angela's

go

Amazon cover image
Image from Amazon.com

Communicable disease control and health protection handbook : [electronic book] /

By: Hawker, Jeremy.
Contributor(s): Begg, Norman [author] | Reintjes, Ralf [author] | Ekdahl, Karl [author] | Edeghere, Obaghe [author] | van Steenbergen, Jim E [author].
Publisher: Newark, N. J. : John Wiley & Sons, 2019Edition: 4th ed.Description: 1 online resource (480 pages).Content type: text Media type: computer Carrier type: online resourceISBN: 9781119328056.Subject(s): Communicable diseases | Public healthDDC classification: 614 Online resources: Access ebook here
Contents:
Intro -- Title Page -- Copyright Page -- Contents -- About the authors -- Foreword -- Abbreviations -- Section 1 Introduction -- 1.1 How to use this book -- 1.2 Basic concepts in the epidemiology of infectious disease -- 1.3 Basic concepts in the prevention of infection -- 1.4 Emergency risk communication -- 1.5 Health protection on-call -- Section 2 Common topics -- 2.1 Meningitis and meningism -- 2.2 Gastrointestinal infection -- 2.3 Community acquired pneumonia -- 2.4 Rash in pregnancy -- 2.5 Rash and fever in children -- 2.6 Illness in returning travellers -- 2.7 Jaundice -- 2.8 Infection in the immunocompromised -- Section 3 Diseases -- 3.1 Amoebic dysentery -- 3.2 Anthrax -- 3.3 Bacillus cereus -- 3.4 Botulism -- 3.5 Brucellosis -- 3.6 Campylobacter -- 3.7 Chickenpox and shingles (varicella-zoster infections) -- 3.8 Chikungunya -- 3.9 Chlamydia pneumoniae -- 3.10 Chlamydia trachomatis -- 3.11 Cholera -- 3.12 CJD and other human transmissible spongiform encephalopathies -- 3.13 Clostridium difficile -- 3.14 Clostridium perfringens -- 3.15 Coronavirus (including MERS and SARS) -- 3.16 Cryptosporidiosis -- 3.17 Cyclosporiasis -- 3.18 Cytomegalovirus -- 3.19 Dengue fever -- 3.20 Diphtheria -- 3.21 Enterococci, including Glycopeptide-Resistant Enterococci (GRE) -- 3.22 Enterovirus infections (including hand, foot and mouth disease) -- 3.23 Epstein-Barr Virus -- 3.24 Giardiasis -- 3.25 Gram-negative bacteraemia (including carbapenem-resistant enterobacteriaceae) -- 3.26 Gonorrhoea, syphilis and other acute STIs -- 3.27 Hantavirus infection -- 3.28 Head lice -- 3.29 Helicobacter pylori -- 3.30 Hepatitis A -- 3.31 Hepatitis B -- 3.32 Hepatitis C -- 3.33 Hepatitis, delta -- 3.34 Hepatitis E -- 3.35 Herpes simplex -- 3.36 Haemophilus influenzae type b (Hib) -- 3.37 HIV -- 3.38 Influenza -- 3.39 Japanese B encephalitis -- 3.40 Legionellosis.
3.41 Leprosy -- 3.42 Leptospirosis -- 3.43 Listeriosis -- 3.44 Lyme disease -- 3.45 Malaria -- 3.46 Measles -- 3.47 Meningococcal infection -- 3.48 MRSA (Meticillin-Resistant Staphylococcus aureus) -- 3.49 Mumps -- 3.50 Mycoplasma pneumoniae infection -- 3.51 Norovirus -- 3.52 Paratyphoid fever -- 3.53 Parvovirus B19 (fifth disease) -- 3.54 Plague -- 3.55 Pneumococcal infection -- 3.56 Poliomyelitis -- 3.57 Psittacosis -- 3.58 Q fever -- 3.59 Rabies -- 3.60 Relapsing fever -- 3.61 Respiratory Syncytial Virus (RSV) -- 3.62 Ringworm -- 3.63 Rotavirus -- 3.64 Rubella -- 3.65 Salmonellosis -- 3.66 Scabies -- 3.67 Schistosomiasis -- 3.68 Shigellosis -- 3.69 Shiga toxin-producing Escherichia coli (STEC) and other diarrhoeagenic E. coli -- 3.70 Smallpox -- 3.71 Staphylococcal food poisoning -- 3.72 Streptococcal infections -- 3.73 Tetanus -- 3.74 Threadworms -- 3.75 Tick-borne Encephalitis -- 3.76 Toxocariasis -- 3.77 Toxoplasmosis -- 3.78 Tuberculosis (and non-tuberculous mycobacteria) -- 3.79 Tularaemia -- 3.80 Typhoid fever -- 3.81 Vibrio parahaemolyticus infection -- 3.82 Viral haemorrhagic fevers, including Ebola -- 3.83 Warts and verrucae (and molluscum contagiosum) -- 3.84 West Nile virus -- 3.85 Whooping cough -- 3.86 Yellow fever -- 3.87 Yersiniosis -- 3.88 Zika virus infection -- 3.89 Other organisms -- 3.89.1 Bacteria -- 3.89.2 Rickettsia, including typhus and ehrlichia -- 3.89.3 Viruses -- 3.89.4 Protozoa -- 3.89.5 Helminths -- 3.89.6 Fungi and actinomycetes -- 3.89.7 Bites, stings, and venoms -- 3.89.8 Chemical food-borne illness -- Section 4 Services and organisations -- 4.1 Surveillance of communicable disease -- 4.2 Managing infectious disease incidents and outbreaks -- 4.3 Community infection control -- 4.4 Hospital infection control -- 4.5 Antimicrobial stewardship -- 4.6 Risks to and from healthcare workers.
4.7 Co-ordination of immunisation services -- 4.8 Co-ordination of sexual health services -- 4.9 Prevention of blood-borne viral infections -- 4.10 Co-ordination of services for tuberculosis control -- 4.11 Travel health -- 4.12 Migrant and refugee health -- 4.13 Emergency preparedness planning and response -- 4.14 Non-infectious environmental hazards -- 4.15 Managing acute chemical incidents -- 4.16 Managing acute radiation incidents -- 4.17 Deliberate release of biological, chemical or radiological hazards -- 4.18 Clinical governance and audit -- 4.19 Global health security -- Section 5 Communicable disease control in Europe -- 5.1 WHO and International Health Regulations -- 5.2 Collaboration within the European Union -- 5.3 Detailed national example: organisational arrangements for health protection, England, 2017 -- 5.4 Austria -- 5.5 Belgium -- 5.6 Bulgaria -- 5.7 Croatia -- 5.8 Cyprus -- 5.9 Czech Republic -- 5.10 Denmark -- 5.11 Estonia -- 5.12 Finland -- 5.13 France -- 5.14 Germany -- 5.15 Greece -- 5.16 Hungary -- 5.17 Iceland -- 5.18 Ireland -- 5.19 Italy -- 5.20 Latvia -- 5.21 Lithuania -- 5.22 Luxembourg -- 5.23 Malta -- 5.24 The Netherlands -- 5.25 Norway -- 5.26 Poland -- 5.27 Portugal -- 5.28 Romania -- 5.29 Slovakia -- 5.30 Slovenia -- 5.31 Spain -- 5.32 Sweden -- 5.33 Switzerland -- 5.34 United Kingdom -- Appendix 1 Guidance documents and books -- Guidance documents and books -- Bloodborne viruses (BBV) -- Immunisation -- Imported infection and travel advice -- Infection control and healthcare acquired infection -- Legionnaires' disease -- Meningitis and meningococcal infection -- Preparedness planning -- Tuberculosis -- Vector-borne diseases -- Other -- Websites containing infectious disease guidelines -- Index -- EULA.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Notes Date due Barcode Item holds
Ebook Ebook ATU Sligo Yeats Library eBook 614 HAW (Browse shelf(Opens below)) Available Online Unlimited access
Total holds: 0

Intro -- Title Page -- Copyright Page -- Contents -- About the authors -- Foreword -- Abbreviations -- Section 1 Introduction -- 1.1 How to use this book -- 1.2 Basic concepts in the epidemiology of infectious disease -- 1.3 Basic concepts in the prevention of infection -- 1.4 Emergency risk communication -- 1.5 Health protection on-call -- Section 2 Common topics -- 2.1 Meningitis and meningism -- 2.2 Gastrointestinal infection -- 2.3 Community acquired pneumonia -- 2.4 Rash in pregnancy -- 2.5 Rash and fever in children -- 2.6 Illness in returning travellers -- 2.7 Jaundice -- 2.8 Infection in the immunocompromised -- Section 3 Diseases -- 3.1 Amoebic dysentery -- 3.2 Anthrax -- 3.3 Bacillus cereus -- 3.4 Botulism -- 3.5 Brucellosis -- 3.6 Campylobacter -- 3.7 Chickenpox and shingles (varicella-zoster infections) -- 3.8 Chikungunya -- 3.9 Chlamydia pneumoniae -- 3.10 Chlamydia trachomatis -- 3.11 Cholera -- 3.12 CJD and other human transmissible spongiform encephalopathies -- 3.13 Clostridium difficile -- 3.14 Clostridium perfringens -- 3.15 Coronavirus (including MERS and SARS) -- 3.16 Cryptosporidiosis -- 3.17 Cyclosporiasis -- 3.18 Cytomegalovirus -- 3.19 Dengue fever -- 3.20 Diphtheria -- 3.21 Enterococci, including Glycopeptide-Resistant Enterococci (GRE) -- 3.22 Enterovirus infections (including hand, foot and mouth disease) -- 3.23 Epstein-Barr Virus -- 3.24 Giardiasis -- 3.25 Gram-negative bacteraemia (including carbapenem-resistant enterobacteriaceae) -- 3.26 Gonorrhoea, syphilis and other acute STIs -- 3.27 Hantavirus infection -- 3.28 Head lice -- 3.29 Helicobacter pylori -- 3.30 Hepatitis A -- 3.31 Hepatitis B -- 3.32 Hepatitis C -- 3.33 Hepatitis, delta -- 3.34 Hepatitis E -- 3.35 Herpes simplex -- 3.36 Haemophilus influenzae type b (Hib) -- 3.37 HIV -- 3.38 Influenza -- 3.39 Japanese B encephalitis -- 3.40 Legionellosis.

3.41 Leprosy -- 3.42 Leptospirosis -- 3.43 Listeriosis -- 3.44 Lyme disease -- 3.45 Malaria -- 3.46 Measles -- 3.47 Meningococcal infection -- 3.48 MRSA (Meticillin-Resistant Staphylococcus aureus) -- 3.49 Mumps -- 3.50 Mycoplasma pneumoniae infection -- 3.51 Norovirus -- 3.52 Paratyphoid fever -- 3.53 Parvovirus B19 (fifth disease) -- 3.54 Plague -- 3.55 Pneumococcal infection -- 3.56 Poliomyelitis -- 3.57 Psittacosis -- 3.58 Q fever -- 3.59 Rabies -- 3.60 Relapsing fever -- 3.61 Respiratory Syncytial Virus (RSV) -- 3.62 Ringworm -- 3.63 Rotavirus -- 3.64 Rubella -- 3.65 Salmonellosis -- 3.66 Scabies -- 3.67 Schistosomiasis -- 3.68 Shigellosis -- 3.69 Shiga toxin-producing Escherichia coli (STEC) and other diarrhoeagenic E. coli -- 3.70 Smallpox -- 3.71 Staphylococcal food poisoning -- 3.72 Streptococcal infections -- 3.73 Tetanus -- 3.74 Threadworms -- 3.75 Tick-borne Encephalitis -- 3.76 Toxocariasis -- 3.77 Toxoplasmosis -- 3.78 Tuberculosis (and non-tuberculous mycobacteria) -- 3.79 Tularaemia -- 3.80 Typhoid fever -- 3.81 Vibrio parahaemolyticus infection -- 3.82 Viral haemorrhagic fevers, including Ebola -- 3.83 Warts and verrucae (and molluscum contagiosum) -- 3.84 West Nile virus -- 3.85 Whooping cough -- 3.86 Yellow fever -- 3.87 Yersiniosis -- 3.88 Zika virus infection -- 3.89 Other organisms -- 3.89.1 Bacteria -- 3.89.2 Rickettsia, including typhus and ehrlichia -- 3.89.3 Viruses -- 3.89.4 Protozoa -- 3.89.5 Helminths -- 3.89.6 Fungi and actinomycetes -- 3.89.7 Bites, stings, and venoms -- 3.89.8 Chemical food-borne illness -- Section 4 Services and organisations -- 4.1 Surveillance of communicable disease -- 4.2 Managing infectious disease incidents and outbreaks -- 4.3 Community infection control -- 4.4 Hospital infection control -- 4.5 Antimicrobial stewardship -- 4.6 Risks to and from healthcare workers.

4.7 Co-ordination of immunisation services -- 4.8 Co-ordination of sexual health services -- 4.9 Prevention of blood-borne viral infections -- 4.10 Co-ordination of services for tuberculosis control -- 4.11 Travel health -- 4.12 Migrant and refugee health -- 4.13 Emergency preparedness planning and response -- 4.14 Non-infectious environmental hazards -- 4.15 Managing acute chemical incidents -- 4.16 Managing acute radiation incidents -- 4.17 Deliberate release of biological, chemical or radiological hazards -- 4.18 Clinical governance and audit -- 4.19 Global health security -- Section 5 Communicable disease control in Europe -- 5.1 WHO and International Health Regulations -- 5.2 Collaboration within the European Union -- 5.3 Detailed national example: organisational arrangements for health protection, England, 2017 -- 5.4 Austria -- 5.5 Belgium -- 5.6 Bulgaria -- 5.7 Croatia -- 5.8 Cyprus -- 5.9 Czech Republic -- 5.10 Denmark -- 5.11 Estonia -- 5.12 Finland -- 5.13 France -- 5.14 Germany -- 5.15 Greece -- 5.16 Hungary -- 5.17 Iceland -- 5.18 Ireland -- 5.19 Italy -- 5.20 Latvia -- 5.21 Lithuania -- 5.22 Luxembourg -- 5.23 Malta -- 5.24 The Netherlands -- 5.25 Norway -- 5.26 Poland -- 5.27 Portugal -- 5.28 Romania -- 5.29 Slovakia -- 5.30 Slovenia -- 5.31 Spain -- 5.32 Sweden -- 5.33 Switzerland -- 5.34 United Kingdom -- Appendix 1 Guidance documents and books -- Guidance documents and books -- Bloodborne viruses (BBV) -- Immunisation -- Imported infection and travel advice -- Infection control and healthcare acquired infection -- Legionnaires' disease -- Meningitis and meningococcal infection -- Preparedness planning -- Tuberculosis -- Vector-borne diseases -- Other -- Websites containing infectious disease guidelines -- Index -- EULA.

Share